Stöhrer, M., Blok, B., Castro-Diaz, D., Chartier-Kastler, E., Del Popolo, G., Kramer, G., et al. (2009) EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Urology, 56, 81-88.
https://doi.org/10.1016/j.eururo.2009.04.028

has been cited by the following article:

• TITLE: Clinical Nursing Recommendations for the Treatment of the BTX-A Injections Due to Neurological Detrusor Overactivity

  AUTHORS: J. M. Lin, Hui Chen, M. P. Huang, Q. L. Liu, Q. Q. Li, T. H. Huang, X. Y. Yang

  KEYWORDS: Botulinum Toxin A, Neurological Detrusor Overactivity, Nursing Care

  JOURNAL NAME: Open Journal of Urology, Vol.9 No.6, June 30, 2019

  ABSTRACT: Background: Neurological detrusor overactivity (NDO) is commonly associated with various neurogenic diseases. Botulinum toxin A (BTX-A) has been proposed as alternatives to traditional treatments. Objective: To summarize the clinical experience of nursing care for the treatment of the Botulinum toxin A (BTX-A) injections due to neurological detrusor overactivity (NDO). Methods: We reviewed the data of 32 inpatients who received BTX-A injections between August 2014 to July 2016. Their mean age was 27.4 years old (range: 19 - 38). They were all on clean intermittent catheterization. All patients presented detrusor overactivity resistant to oral anticholinergic treatment. Results: There were significant difference between outcomes at baseline and week12 for Pdetmax (60.08 cmH2O vs. 28.04 cmH2O, P Conclusions: Patients were satisfied with the treatment and nursing by targeted perioperative nursing.